Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
New England Journal of Medicine · 12.09.2024 · 391 (10) · 885-898
DOI: 10.1056/nejmoa2400858 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 12.09.2024. Verfasst von Andreas Hochhaus und 22 weiteren Autor:innen. Beteiligte Einrichtung: From Klinik für Innere Medizin II, Hematology/Oncology, Universitätsklinikum Jena and Comprehensive Cancer Center Central Germany, Campus Jena, Jena …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Fusion Proteins, bcr-abl, Imatinib Mesylate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Die Arbeit wurde bisher 184-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Cancer Research UK, Novartis Pharma AG.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Klinik für Innere Medizin II, Hematology/Oncology, Universitätsklinikum Jena and Comprehensive Cancer Center Central Germany, Campus Jena, Jena (A.H.), and the Department of Oncology and Hematology, Charité-Univers…
Förderung
- Cancer Research UK
- Novartis Pharma AG
Zitieren
APA
Hochhaus, A., Wang, J., Kim, D. W., Kim, D. D. H., Mayer, J., Goh, Y. T., le Coutre, P., Takahashi, N., Kim, I., Etienne, G., Andorsky, D., Issa, G. C., Larson, R. A., Bombaci, F., Kapoor, S., McCulloch, T., Malek, K., Yau, L., Ifrah, S., …, & ASC4FIRST Investigators (2024). Asciminib in Newly Diagnosed Chronic Myeloid Leukemia. New England Journal of Medicine, 391(10), 885-898. https://doi.org/10.1056/nejmoa2400858
Vancouver
Hochhaus A, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, et al. Asciminib in Newly Diagnosed Chronic Myeloid Leukemia. New England Journal of Medicine. 2024;391(10):885-898. doi:10.1056/nejmoa2400858
BibTeX
@article{Hochhaus2024,
author = {Hochhaus, Andreas and Wang, Jianxiang and Kim, Dong-Wook and Kim, Dennis Dong Hwan and Mayer, Jiri and Goh, Yeow-Tee and le Coutre, Philipp and Takahashi, Naoto and Kim, Inho and Etienne, Gabriel and Andorsky, David and Issa, Ghayas C and Larson, Richard A and Bombaci, Felice and Kapoor, Shruti and McCulloch, Tracey and Malek, Kamel and Yau, Lillian and Ifrah, Sophie and Hoch, Matthias and Cortes, Jorge E and Hughes, Timothy P and ASC4FIRST Investigators, ASC4FIRST Investigators},
title = {Asciminib in Newly Diagnosed Chronic Myeloid Leukemia},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {10},
pages = {885--898},
doi = {10.1056/nejmoa2400858}
}
EUVIMED